戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 utophagy-initiating TBK1 kinase and the ULK1 kinase complex.
2  parasites by interference with the virulent kinase complex.
3  promotes Wts phosphorylation by the Hpo-Sav kinase complex.
4 f the exocyst by a specific cyclin-dependent kinase complex.
5 subunits actually mediate(s) docking of this kinase complex.
6 ibitors, a process controlled by the IkappaB kinase complex.
7 ppaB (NF-kappaB) is activated by the IkappaB kinase complex.
8 tion of the human ITS2 pre-rRNA endonuclease-kinase complex.
9 rging on the Autophagy-Related1 (ATG1)/ATG13 kinase complex.
10 A, to activation of the ATR-ATRIP checkpoint kinase complex.
11 and Ku80 components in DNA-dependent protein kinase complex.
12 R-1 activation to stimulation of the IkappaB kinase complex.
13 ch activates the TAK1 (also known as MAP3K7) kinase complex.
14 ation of the Ret/GFRalpha3 receptor tyrosine kinase complex.
15  activity regulate a cyclin/cyclin-dependent kinase complex.
16  the catalytic subunit of the CDK-activating kinase complex.
17 gamma, the regulatory subunit of the IkappaB kinase complex.
18 plex, which in turn activates the Warts/Mats kinase complex.
19 ubstrates compared with another Pho85-cyclin kinase complex.
20 the inhibitor of nuclear factor (NF)- kappaB kinase complex.
21 4 signal pathway was proximal to the IkappaB kinase complex.
22 IKKalpha, one of the subunits of the IkappaB kinase complex.
23 nd the IKKalpha/beta subunits of the IkappaB kinase complex.
24    This condensation depends on the aurora B kinase complex.
25 ion of the kinase and cyclin subunits of the kinase complex.
26 tion of the IRS-1/p85 phosphatidylinositol 3-kinase complex.
27  US28 stimulates the production of a FAK.Src kinase complex.
28 kinase stimulation in the assembled receptor-kinase complex.
29  between Bcl10 and activation of the IkappaB kinase complex.
30  of an open, uninhibited conformation of the kinase complex.
31 osphatidylinositol 3-kinase complex I) lipid kinase complex.
32 that mediates the degradation of the IkappaB kinase complex.
33 ly suppressing the activation of the IkappaB kinase complex.
34 gamma, encoding the gamma subunit of the AMP Kinase complex.
35 the action of the Atg14-containing Vps34 PI3 kinase complex.
36  one signaling pathway regulated by the TAK1 kinase complex.
37 s do not inhibit or associate with the Hippo kinase complex.
38 microscopy structure of the Hsp90-Cdc37-Cdk4 kinase complex.
39 her components of the phosphatidylinositol 3-kinase complex.
40 ved the activation of the BECN1/PIK3C3 lipid kinase complex.
41  but independent of the ULK and VPS34-beclin kinase complexes.
42 oteins), and mitogen-activated protein (MAP) kinase complexes.
43 nding of cell cycle inhibitor p27Kip1 to the kinase complexes.
44 ough inhibition of target of rapamycin (TOR) kinase complex 1 (TORC1) activity.
45                  The rapamycin-sensitive Tor kinase complex 1 (TORC1) has a major role in regulating
46             In nutrient-rich conditions, Tor kinase complex 1 (TORC1) is activated to inhibit autopha
47                      The target of rapamycin kinase complex 1 (TORC1) regulates cell growth and metab
48                          Target of rapamycin kinase complex 1 (TORC1) regulates Pol III activity, and
49                  The rapamycin-sensitive Tor kinase complex 1 is a major regulator of autophagy.
50                     We report here that mTOR kinase complexes 1 and 2 (mTORC1 and mTORC2) are essenti
51 permeable peptide inhibitor of the I kappa B-kinase complex, a crucial component of signal transducti
52 tivated through phosphorylation by the TORC1 kinase complex, a sensor of nutrient availability.
53 or-associated kinase, IkappaB-alpha, IkappaB kinase complex-alpha/beta, and phospholipase-gamma1 and
54                                   The Aurora kinase complex, also called the chromosomal passenger co
55 osphatidylethanolamine, as well as a protein kinase complex and a phosphatidylinositol 3-kinase compl
56 ere associated with the reduction of IkappaB kinase complex and c-Jun NH(2)-terminal kinase activatio
57 (positive transcription elongation factor b) kinase complex and for its recruitment to chromatin.
58 tment resulted in degradation of the IkappaB kinase complex and inhibition of NF-kappaB through stabi
59 of the Ku70, Ku80, and DNA-dependent protein kinase complex and is conveyed to the recipient cell by
60 ough the catalytic components of the IkappaB kinase complex and leads to IkappaB phosphorylation, deg
61 le inhibitor 2c blocks assembly of the multi-kinase complex and represses HIV-1-mediated MHC-I down-r
62 paB signaling via its effects on the IkappaB kinase complex and resulting in reduced IL2 gene express
63 ed by a rapid phosphorylation of the IkappaB kinase complex and subsequent degradation of the NF-kapp
64  Chiffon to form a functional Dbf4-dependent kinase complex and that Cdc7 is necessary for DNA replic
65 , absent from previous structures, a protein kinase complex and the Mediator-activator interaction re
66   At lysosomes and endosomes, the Fab1 lipid kinase complex and the nutrient-regulated target of rapa
67 -like autophagy activating kinase 1) protein kinase complex and the PI3KC3-C1 (class III phosphatidyl
68 hrough the inactivation of the Cdk1-cyclin B kinase complex and the reversal of its phosphorylation e
69 so requires the Uvrag-containing Vps34 lipid kinase complex and the v-ATPase proton pump, whereas Atg
70 rotein signaling complexes, such as the ULK1 kinase complex and the Vps34 lipid kinase complex, which
71 -cell lymphomas: inhibition of the Jak1/Jak3 kinase complex and, given the known strong immunostimula
72 ically its role in the activation of protein kinase complexes and in coordination of cell survival an
73  chains act as scaffolds to assemble protein kinase complexes and mediate their activation through pr
74             IFREDA was used in eight protein kinase complexes and was able to find the correct ligand
75  p21 can interact both with cyclin-dependent kinase complexes and with proliferating cell nuclear ant
76 L)-VPS34 (a class III phosphatidylinositol 3-kinase) complex and its product phosphatidylinositol 3-p
77 [ataxia-telangiectasia mutated]-Rad3-related kinase) complex and the Rad9-Hus1-Rad1 (9-1-1) clamp.
78 Balpha (IkappaBalpha), activation of IkappaB kinase complex, and c-Jun NH(2)-terminal kinase and, sub
79 Rad1-Hus1 clamp, the Rad3(ATR) -Rad26(ATRIP) kinase complex, and the Crb2(53BP1) mediator.
80 composed of NEMO, a component of the IkappaB kinase complex, and the death domain of RIP (NEMO-DD) ca
81 n ligase complex, components of the PtdIns 3-kinase complex, and the ESCRT machinery.
82 purified proteins, including TRAF6, the TAK1 kinase complex, and Ub-conjugating enzyme complex Ubc13-
83 roviding viral decoy substrates for cellular kinase complexes, and through direct blocking of the IFN
84  kinase complex and a phosphatidylinositol 3-kinase complex are also required for macroautophagy in y
85 c;2 and cyct1;5 mutants, indicating that the kinase complexes are important for transcription from th
86 ycles that regulate the activity of receptor-kinase complexes are ultrasensitive because they operate
87 of the striatin interaction phosphatases and kinases complex, are multidomain scaffolding proteins th
88     These results establish Arabidopsis CDKC kinase complexes as important host targets of CaMV for t
89 he cyclin E/cyclin-dependent kinase 2 (CDK2) kinase complex, as a key coactivator to enhance histone
90  heterodimer, nominally considered a mitotic kinase complex, as a novel binding partner of 53BP1.
91 ranscription at a point distal to the Ikappa kinase complex, as only ectopic expression of the NFkapp
92 tization occurs well upstream of the IkappaB kinase complex, as protein kinase C translocation to the
93 F-regulated scaffold that modulates receptor kinase complex assembly.
94           However, in the absence of S-phase kinases complex assembly is inhibited, which is unexpect
95  20 and a corresponding reduction in ikappaB kinase complex associated protein (IKAP) levels.
96 ponding reduction of the inhibitor of kappaB kinase complex-associated protein (IKAP), also known as
97  of its encoded protein, inhibitor of kappaB kinase complex-associated protein (IKAP).
98  a mutation in the gene inhibitor of kappa B kinase complex-associated protein (IKBKAP).
99 dysautonomia patients with IKBKAP (I-kappa-B kinase complex-associated protein) mutation compared to
100 s point mutation in IKBKAP, encoding IkappaB kinase complex-associated protein.
101 machinery immediately downstream of the Atg1 kinase complex at phagophore assembly sites.
102 s the mammalian target of rapamycin (mTORC1) kinase complex at the lysosomal surface.
103 g1/Unc-51-like autophagy activating kinase 1 kinase complex, autophagic receptor proteins, and mammal
104                                     The Ctk1 kinase complex binds RNA in vitro, consistent with direc
105 (cryo-EM) reconstruction of a human SMG1-8-9 kinase complex bound to a UPF1 phosphorylation site at a
106 ompromises the recruitment of Cdc37 to Hsp90-kinase complexes but has only modest effects on its basa
107 unction for activation of the IKK kinase (or kinase complex), but none form a stable complex with IKK
108 mplex), linked to the inhibitor of NF-kappaB kinase complex, but signal transduction is not fully und
109 ccurs via sequestration of the active P-TEFb kinase complex (CDK 9 and Cyclin T1/T2a/b or K) that is
110                                 Another Ser2 kinase complex, CDK-12/cyclin K, which requires upstream
111 nance energy transfer that active LKB1/STRAD kinase complex colocalizes with E-cadherin at AJs.
112  two phosphatidylinositol 3-kinase (PtdIns 3-kinase) complexes: complex I is required for autophagy,
113 d chemical and mechanical insults activate a kinase complex composed of IkappaB kinase beta (IKK-beta
114 ally upstream of the noncanonical regulatory kinase complex composed of NIK.IKKalpha subunits.
115 ation showed altered interactions with Hsp90-kinase complexes consistent with compromised Cdc37 modul
116 on of NF-kappaB and IKK requires an upstream kinase complex consisting of TAK1 and adaptor proteins s
117 ion factor NF-kappaB is activated by the IKK kinase complex containing two kinases (IKKalpha and IKKb
118 ways by functioning as a scaffold to recruit kinase complexes containing ubiquitin-binding domains.
119              We show that the CapAB tyrosine kinase complex controls multiple enzymatic checkpoints t
120  cyclin-dependent kinase (CDK) 2-cyclin E, a kinase complex critical for the initiation of centrosome
121 with Ctk2 and Ctk3 to form an active protein kinase complex, CTDK-I.
122 ase II carboxyl terminal domain (RNAPII CTD) kinase complex (CTK complex) is known as a positive elon
123 ophila melanogaster cyclin-dependent protein kinase complex CycD/Cdk4 stimulates both cell cycle prog
124      The Drosophila cyclin-dependent protein kinase complex Cyclin D/Cdk4 induces cell growth (accumu
125 -docking site on Nud1, to which the effector kinase complex Dbf2-Mob1 bound through a phosphoserine-t
126 resses RIP3-RIP1 (also known as RIPK3-RIPK1) kinase complex-dependent necroptosis that follows death
127 egulation by Hippo and to associate with the kinase complex directly correlate with their capacity to
128 us was associated with increased DNA protein kinase complex (DNA-PK) activity.
129 ase beta, a catalytic subunit of the IkappaB kinase complex essential for NF-kappaB activation, fails
130                    Inhibition of the IkappaB kinase complex essentially ablated all cytokine inductio
131 ed transient insolubilization of the IkappaB kinase complex following its dissociation from Hsp90 rep
132 ity, which occurred by inhibition of IkappaB kinase complex formation rather than by a direct effect
133 y, we showed that Hh signaling inhibits Cos2-kinase complex formation.
134  18BIOder preferentially inhibits this novel kinase complex from infected cells at nanomolar concentr
135 ally available crystal structures of protein kinases complexes have motivated structural bioinformati
136 entration of ATP above 1.2 mM and makes this kinase complex highly sensitive to ATP depletion.
137 ssociate with C9ORF72 or with a C9ORF72-ULK1 kinase complex holo-assembly, which function in maturati
138 ct myotubularin binding to the type III PI 3-kinase complex hVps34/hVps15 leads to phosphatase inacti
139  autophagic class III phosphatidylinositol-3 kinase complex I (PI3KC3-C1) and conjugation of ATG8/LC3
140         The class III phosphatidylinositol 3-kinase complex I (PI3KC3-C1) is central to autophagy ini
141         The class III phosphatidylinositol 3-kinase complex I (PI3KC3-C1) is required for the initiat
142         The class III phosphatidylinositol 3-kinase complex I (PI3KC3-C1) that functions in early aut
143 of the class III phosphatidylinositol (PI) 3-kinase complex I (PI3KC3-C1).
144 ell is controlled by the target of rapamycin kinase complex I (TORC1) and cAMP-dependent protein kina
145  PI3KC3-C1 (class III phosphatidylinositol 3-kinase complex I) lipid kinase complex.
146 ed protein kinases Atg1, target of rapamycin kinase complex I, and protein kinase A (PKA) regulate au
147     The class III phosphatidylinositol (PI)3-kinase complexes I and II (PI3KC3-C1 and -C2) are essent
148  (PI(3)P) produced by the phosphoinositide 3-kinase complex II.
149 the NF-kappaB-activating inhibitor of kappaB kinase complex IKK-alpha/beta and active transcription f
150 or is demonstrated to signal through IkappaB kinase complex (IKK) 2 > IkappaB > nuclear factor kappaB
151 ation and degradation, inhibition of IkappaB kinase complex (IKK) activation, suppression of p65 phos
152 ay components functioned upstream of IkappaB kinase complex (IKK) activation.
153 , which subsequently activates the I-kappa B kinase complex (IKK) and mitogen-activated protein (MAP)
154 s required for the activation of the IkappaB kinase complex (IKK) by inflammatory stimuli such as tum
155                    Inhibition of the IkappaB kinase complex (IKK) has been implicated in the therapy
156 hat both TNF and LPS activated the I-kappa B kinase complex (IKK) in DPSCs to induce the phosphorylat
157                                  The IkappaB kinase complex (IKK) is a key regulator of immune respon
158                                  The IkappaB kinase complex (IKK) is central to the activation of NF-
159                       A multisubunit IkappaB kinase complex (IKK) phosphorylates IkappaB proteins and
160                                  The IkappaB kinase complex (IKK) that phosphorylates IkappaB contain
161 genic mice, mutant Htt activates the IkappaB kinase complex (IKK), a key regulator of NF-kappaB.
162 1, TNFR2, NF-kappaB-inducing kinase, IkappaB kinase complex (IKK), and the p65 subunit of NF-kappaB.
163 panied by enhanced activation of the IkappaB kinase complex (IKK), which is responsible for targeting
164 of NF-kappaBeta (IkappaBeta), and IkappaBeta kinase complex (IKK).
165 of NEMO, a regulatory subunit of the IkappaB kinase complex (IKK).
166 actor-kappaB (NF-kappaB) through the IkappaB kinase complex (IKK).
167                                  The IkappaB kinase complex (IKK)/NF-kappaB and JNK/AP-1 pathways are
168 ses and is tightly controlled by the IkappaB kinase complex (IKK-alpha/beta/gamma).
169 and activation of a key NF-kappaB activating kinase complex, IKK.
170 the gamma subunit of the inhibitor of kappaB kinase complex (IKKgamma; commonly referred to as the NF
171            The structure captures the kinase-kinase complex in a precatalytic state where the activat
172 Here, we describe a role for the Hippo (Hpo) kinase complex in promoting Partner of Inscuteable (Pins
173 he involvement of a GP Ibalpha/14-3-3xi/PI-3 kinase complex in regulating thrombopoietin-mediated res
174 and degradation upon activation of the TORC1 kinase complex in response to an increase in internal am
175  and the formation of a novel focal adhesion kinase complex in response to ErbB2 activation in mammar
176  defined an essential role for the Dbf4-Cdc7 kinase complex in the initiation of DNA replication pres
177 ells only, by sequestering a cytosolic Hippo kinase complex in which LATS kinase is inhibited.
178 raction, binds LIT-1 and thereby generates a kinase complex in which LIT-1 molecules are situated in
179 , exists in two essential, yet distinct, TOR kinase complexes in the budding yeast Saccharomyces cere
180 nteractions with activated receptor tyrosine kinase complexes including the CD19 subunit of the B-cel
181 ession and increased cyclin/cyclin-dependent kinase complex inhibitor p27kipl expression.
182 scopy, we investigated whether this cellular kinase complex interacts with IE62.
183 converts the transient noncovalent substrate-kinase complex into a covalently cross-linked product by
184 gy in S. cerevisiae, and that the Atg1/Atg13 kinase complex is a key site of signal integration withi
185 a-induced activation of p38, ERK, or IkappaB kinase complex is affected by the loss of Miz1.
186                              The Sid2p-Mob1p kinase complex is an important component of the septatio
187                                         This kinase complex is assembled by mTOR and its essential co
188 ted)-ATRIP (ATR-interacting protein) protein kinase complex is central to the cellular response to re
189 ted)-ATRIP (ATR-interacting protein) protein kinase complex is crucial for the cellular response to r
190   In its absence, activation of the TAK1-IKK kinase complex is defective, greatly reducing signal tra
191 e, we report that the NF-kappaB inducing IKK kinase complex is localized at the postsynaptic density
192 sites on ATR and ATRIP to understand how the kinase complex is regulated by post-translational modifi
193                             The Snf1 protein kinase complex is required for activation of their downs
194                Furthermore, the Snf1 protein kinase complex is required to adapt cellular metabolism
195              The multiprotein mTORC1 protein kinase complex is the central component of a pathway tha
196 e phosphorylation by Src/FAK (focal adhesion kinase) complex is essential for F-actin binding of ACF7
197 a possible target of the PAR-4-STRD-1-MOP-25 kinase complex, is also required for cell shedding.
198 mycin complex-2 (TORC2), a conserved protein kinase complex, is an indispensable regulator of plasma
199 , generated exclusively by the PIKfyve lipid kinase complex, is key for lysosomal biology.
200  be a kinase that acts as part of a receptor kinase complex, is likely to be a pseudokinase and not a
201 ngements in the alpha(v)beta(3) integrin-Lyn kinase complex leading to disruption of Lyn kinase-media
202 motes phosphorylation of AMPK by an upstream kinase complex, LKB1/Mo25/STRAD (liver kinase B 1, mouse
203 ta, and gamma) of the positively acting Snf1 kinase complex localize to the nuclear periphery, result
204                     The serine and threonine kinase complex, mammalian target of rapamycin complex 1
205   For Pah1 phosphorylated by the Pho85-Pho80 kinase complex, maximum Nem1-Spo7 phosphatase activity r
206                                          The kinase complex mechanistic target of rapamycin 1 (mTORC1
207 e class III PtdIns3 (phosphatidylinositol 3) kinase complexes, mediates the production of PtdIns3P, a
208 ere we present evidence that the MEN protein kinase complex Mob1p-Dbf2p localizes to mitotic nuclei a
209 ed but functionally distinct multi-component kinase complexes, mTOR complex 1 (mTORC1) and mTORC2.
210 kinase) and Akt and the metabolic checkpoint kinase complex mTORC1 (mammalian target of rapamycin) an
211 ucine for activation of the serine-threonine kinase complex mTORC1 and for expression of the transcri
212                At present, inhibitors of the kinase complex mTORC1 are undergoing clinical trials.
213          We also identify signalling via the kinase complex mTORC1 as a central regulator of T(H)17-c
214 ls had more activity of the serine-threonine kinase complex mTORC1 but less mTORC2 activity, and acti
215 nine kinase Akt and the metabolic checkpoint kinase complex mTORC1 induces both expression of the glu
216 tophagy and mitophagy markers, even when the kinase complex mTORC1, an inhibitor of the autophagy, is
217                  Dual inhibition of the mTOR kinase complexes mTORC1 and mTORC2 decreases tumor xenog
218                 The PI3K-dependent signaling kinase complex mTORC2 (mammalian target of rapamycin com
219 gulates activity of the metabolic checkpoint kinase complex mTORC2 and the serine-threonine kinase Ak
220 manner dependent on the metabolic checkpoint kinase complex mTORC2.
221 s physically with Sid2p and Mob1p, a protein kinase complex of the septation initiation network, and
222      mAbs capable of disabling heterodimeric kinase complexes of the epidermal growth factor receptor
223                  Retention of these receptor-kinase complexes on the cell surface was dependent on th
224  effect of different cyclin-cyclin-dependent kinase complexes on ubiquitination of p27 in a reconstit
225 egatively regulated by the phosphate-sensing kinase complex Pho80p/Pho85p and by the nitrogen-sensing
226 lates focal class III phosphatidylinositol 3-kinase complex (PI3KC3) activity, which is required to i
227  of the endolysosomal phosphatidylinositol 3-kinase complex (PI3KC3-C2)-which contains beclin 1 and U
228  post-translational modifications and cyclin-kinase complexes play roles at the heart of the cell div
229 ective autophagic degradation of the IkappaB kinase complex prevents constitutive activation of the i
230  determined if disruption of the Hsp90-eEF-2 kinase complex promoted degradation of the kinase.
231 ator of the class III phosphatidylinositol 3-kinase complex, promotes membrane tethering of protein-f
232 of erythropoietin (EPO) receptor (EPOR) JAK2 kinase complexes propagates signals within erythroid pro
233 istance exercise act to regulate the protein kinase complex referred to as mechanistic target of rapa
234                                The ATR-ATRIP kinase complex regulates cellular responses to DNA damag
235                  The Drosophila PAN GU (PNG) kinase complex regulates the developmental translation o
236 pathways, the key inputs and outputs of this kinase complex remain unknown.
237 t, IkappaB kinase (IKK)gamma, of the central kinase complex required for NF-kappaB activation, IKK, o
238 rain, we found the Cl(-)-sensitive WNK3-SPAK kinase complex, required for cell shrinkage-induced regu
239 of the autophagy-initiating ULK and the TBK1 kinase complex, respectively.
240  are the regulatory subunits of IKK and TAK1 kinase complexes, respectively.
241 omponent of class III phosphatidylinositol-3-kinase complexes responsible for autophagosome nucleatio
242  A crystal structure of the PF-06463922-ROS1 kinase complex revealed favorable interactions contribut
243              Crystal structures of inhibitor-kinase complexes showed that the inhibitor stabilizes a
244  of the striatin-interacting phosphatase and kinase complex (STRIPAK).
245 function by recruiting the ULK1/2 initiation kinase complex subunit ATG13 to nascent autophagosomes.
246  gliomagenesis by stabilizing cyclin D1-cdk4 kinase complexes, suggesting that cyclin D1 and cdk4 may
247 ) forms two conserved, structurally distinct kinase complexes termed TOR complex 1 (TORC1) and TORC2.
248           Here we report that removal of the kinase complex TFIIK from TFIIH shifts the TSS in a yeas
249 F2p is the catalytic subunit of a regulatory kinase complex that controls flagellar length and flagel
250 INCENP), a subunit of the conserved Aurora B kinase complex that forms part of the proposed chromosom
251 he phosphoinositide 3-kinase class III lipid-kinase complex that induces autophagy, as an interacting
252  the PI(3) kinase class III (PI(3)KC3) lipid-kinase complex that induces autophagy.
253 tial component of the Beclin1-PI(3)KC3 lipid kinase complex that is an important signalling checkpoin
254 se kinase (ASK), a component of the Cdc7/ASK kinase complex that is crucial for cell proliferation, b
255 atory subunits of a cyclin-dependent protein kinase complex that is essential for normal growth and h
256  kinase alpha (IKKalpha), a component of the kinase complex that leads to NF-kappaB activation, plays
257 of rapamycin complex 1 (mTORC1) is a protein kinase complex that localizes to lysosomes to up-regulat
258     Here, we characterize a new K(+) channel-kinase complex that operates in the metazoan Caenorhabdi
259 n target of rapamycin) complex 2 (mTORC2), a kinase complex that phosphorylates Akt at Ser473 upon ac
260 arget of rapamycin complex 1 (mTORC1), a key kinase complex that regulates cell size and growth, is o
261 PNG, PLU, and GNU constitute a novel protein kinase complex that specifically regulates S-M cell cycl
262 ng with the formation of Ci-Sufu and Ci-Cos2-kinase complexes that normally inhibit Ci activity and p
263 accharomyces cerevisiae Mec1-Ddc2 checkpoint kinase complex (the ortholog to human ATR-ATRIP) is an e
264 ; and (3) a membrane-protein phosphatase and kinase complex, the STRIPAK complex, bridges the cis-Gol
265                            Tat binds to this kinase complex through a direct protein-protein interact
266  PDK1 associates with the core Hippo pathway-kinase complex through the scaffold protein Salvador.
267 or kappaB (IkappaB) proteins and the IkappaB kinase complex through two major pathways: the canonical
268 lates the IKKbeta subunit within the IkappaB kinase complex to activate NF-kappaB-regulated genes.
269 ul3 ubiquitin complex acted on the wnk4-wnk1 kinase complex to regulate Na(+)/Cl(-) cotransporter (NC
270 essential for the translocation of the LIT-1 kinase complex to the nucleus, the site of its TCF subst
271 induction, and recruitment of the Atg1-Atg13 kinase complex to the pre-autophagosomal structure by st
272 ection, Nef assembles the 2c-sensitive multi-kinase complex to trigger down-regulation of cell-surfac
273  pseudokinases that regulate multiple active kinase complexes to synergistically thwart innate immuni
274 a-arrestin, which is activated via the TORC1 kinase complex upon arginine uptake.
275 e cyclin D1/cyclin-dependent kinase 4 (CDK4) kinase complex, used as a surrogate for cyclin D1 degrad
276 ectivities, and X-ray structures of the drug-kinase complexes using a VEGFR2 TK construct inclusive o
277 ivators Gal4 and VP16 target the Snf1 (AMPK) kinase complex via direct interactions with both the cor
278 tituted kinase assay, in which an active PKR kinase complex was captured from a normal cell extract,
279 The phosphorylation site(s) of K-cyclin/Cdk9 kinase complexes was mapped in the transactivation domai
280 imilar analysis of several constructs of the kinase complex, we propose that assembly is characterize
281  upon overexpression of A1PiZ, both PtdIns 3-kinase complexes were required for delivery of the exces
282  the TNF-alpha-induced pronecrotic RIP1-RIP3 kinase complex, whereas the IkappaB Kinase (IKK) subunit
283 s occurred through activation of the IkappaB kinase complex, which also led to activation of NF-kappa
284 lated by the AUTOPHAGY-RELATED1/13 (ATG1/13) kinase complex, which connects metabolic and environment
285 ine stimulation is controlled by the IkappaB kinase complex, which contains IKKalpha and IKKbeta.
286  the ULK1 kinase complex and the Vps34 lipid kinase complex, which generates phosphatidylinositol 3-p
287 control the activation of the Hippo/Salvador kinase complex, which in turn activates the Warts/Mats k
288 autophagy depends on the autophagy-related 1 kinase complex, which is also essential for TORC1-regula
289      Both proteins are connected to the Atg1 kinase complex, which is involved in autophagy initiatio
290 m through the kinase activity of the IkappaB kinase complex, which leads to translocation of NF-kappa
291 lates the kinase activity of DNA-PK (protein kinase) complexes, which leads to increased phosphorylat
292 nslation, regulated in Drosophila by the PNG kinase complex whose activity we show here to be under p
293  small interfering RNA, blocking the IkappaB kinase complex with BMS-345541, or using the proteasome
294  association of alpha(v)beta(3) integrin-Lyn kinase complex with ionotropic glutamate receptor subuni
295 ps30, are scaffold proteins bound in a lipid kinase complex with multiple cellular functions, includi
296  the TANK-binding kinase 1-inducible IkappaB kinase complex with upstream signaling molecules in mult
297                       Cyclin B3 forms active kinase complexes with CDK1, and meiotic progression requ
298 performing energy minimizations of inhibitor-kinase complexes with the molecular mechanics code GROMA
299  DFG motif as compared to that seen in other kinase complexes with VX-680.
300  two novel regulatory components of the Stt4 kinase complex, Ypp1 and Efr3.

 
Page Top